OHR Pharmaceutical | Evaluate

November 27, 2017

Regeneron needs a new plan B for Eylea

February 10, 2016

Roche gets back to business – R&D upgrades and downgrades

April 10, 2015

Good times roll in Q1 as mid and small cap winners outnumber losers

September 22, 2014

Still unpartnered, but now worth a lot more

April 14, 2014

Lombard postpones IPO as US indices decline

September 03, 2013

Therapeutic focus – Big pharma adds weight to thin cachexia pipeline

January 06, 2012

Small caps produce clear winners and losers in 2011

May 12, 2011

Therapeutic focus - Cachexia pipeline gaining weight